# Menorrhagia Study in Women With Treatment-resistant Menorrhagia

> **NCT00288691** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 26 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** Asoprisnil (BAY86-5294)
- **DRUG:** Asoprisnil (BAY86-5294)
- **DRUG:** Asoprisnil (BAY86-5294)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00288691
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288691, "Menorrhagia Study in Women With Treatment-resistant Menorrhagia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00288691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*